Loading...
Calumet Inc (CLMT) is not a strong buy at the moment for a beginner investor with a long-term focus. Despite some positive catalysts like the Montana Renewables agreement and bullish technical indicators, the company's recent financial performance shows significant declines in revenue, net income, and EPS. Insider selling and a lack of strong proprietary trading signals further weaken the case for immediate investment. Waiting for the upcoming earnings report on February 27, 2026, could provide better clarity on the company's trajectory.
The technical indicators show mixed signals. The MACD is positive, indicating bullish momentum, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the RSI is at 90.508, signaling an overbought condition. The stock is trading near its resistance level of 29.184, with support at 24.707.

Agreement with World Energy Clean Fuels to deliver 70 million gallons of Sustainable Aviation Fuel, reducing CO2 emissions and supporting agriculture.
Analysts have raised price targets recently, with some maintaining Buy ratings.
Bullish technical indicators such as MACD and moving averages.
Significant insider selling, with a 12013.98% increase in the last month.
Poor financial performance in Q3 2025, with revenue, net income, and EPS showing sharp declines.
Lack of proprietary trading signals (AI Stock Picker and SwingMax).
Elevated leverage and uncertainty around Montana Renewables' operations.
In Q3 2025, revenue dropped by -2.04% YoY to $1.078 billion. Net income plummeted by -411.53% YoY to $313.4 million, and EPS fell by -405.93% YoY to 3.61. However, gross margin increased significantly to 34.67%, up 7604.44% YoY.
Analysts have mixed views. UBS raised the price target to $26 but maintained a Neutral rating. BofA and Goldman Sachs raised their price targets to $28 and $24, respectively, and maintained Buy ratings, citing potential catalysts and margin momentum. TD Cowen raised the target to $19 but maintained a Hold rating, citing uncertainties in Montana Renewables' operations.